title: A preliminary evaluation of accelerator mass spectrometry in the biomedical field.
authors.affiliation: Department of Drug Metabolism, Pfizer Central Research, Sandwich, Kent, UK.
authors.forename: B
authors.initials: B
authors.lastname: Kaye
authors.forename: R C
authors.initials: RC
authors.lastname: Garner
authors.forename: R J
authors.initials: RJ
authors.lastname: Mauthe
authors.forename: S P
authors.initials: SP
authors.lastname: Freeman
authors.forename: K W
authors.initials: KW
authors.lastname: Turteltaub
mesh_terms: D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000493:pharmacokinetics; D001698:Biomedical Engineering; D002247:Carbon Isotopes; D002250:Carbon Radioisotopes; D006801:Humans; D007189:Indans / Q000493:pharmacokinetics; D013058:Mass Spectrometry / Q000295:instrumentation*; D010315:Particle Accelerators; D010627:Phenethylamines / Q000493:pharmacokinetics; D011422:Propionates / Q000493:pharmacokinetics; D011480:Protease Inhibitors / Q000493:pharmacokinetics; D051381:Rats; D013449:Sulfonamides / Q000493:pharmacokinetics
chemical_list: D000889:Anti-Arrhythmia Agents; D002247:Carbon Isotopes; D002250:Carbon Radioisotopes; D007189:Indans; D010627:Phenethylamines; D011422:Propionates; D011480:Protease Inhibitors; D013449:Sulfonamides; C062766:candoxatril; C063533:dofetilide